NCT04616924Phase 3Terminated

RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease

Study sponsor: RedHill Biopharma Limited

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2023-08-28Actual
Enrollment · participants12Actual
Source updated2025-03-18Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.